FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes​

FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes​

FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes​

 The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.  

Creator: The New York Times (NYTHealth)

Related Posts

Wildlife Habitat Protection in a Rapidly Changing World
Wildlife Habitat Protection
Energy Independence Solutions for a More Resilient Future
Energy Independence Solutions
Ebola Spillover Risk and the Growing Threat of Outbreaks
Ebola Spillover Risk

Most Recent

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts